We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALACT market cap is 7.88M. The company's latest EPS is EUR -1.1831 and P/E is -0.41.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 1.57M | 1.48M | 3M | 2.7M | 2.63M |
Operating Income | -5.17M | -7.58M | -11.89M | -15.12M | -17.57M |
Net Income | -5.05M | -7.65M | -12.61M | -15.88M | -18.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 15.4M | 11.02M | 17.88M | 12.94M | 9.72M |
Total Liabilities | 6.37M | 9.3M | 6.86M | 15.19M | 15.03M |
Total Equity | 9.03M | 1.72M | 11.02M | -2.24M | -5.31M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -4.28M | -6.74M | -13.75M | -12.1M | -13.02M |
Investing | 326k | -53k | -12k | -66k | -46k |
Financing | 6.64M | 1.5M | 17.52M | 7.42M | 10.36M |
Market Cap | 7.88M |
Price to Earnings Ratio | -0.41 |
Price to Sales Ratio | 2.88 |
Price to Cash Ratio | 1.95 |
Price to Book Ratio | -1.42 |
Dividend Yield | - |
Shares Outstanding | 15.76M |
Average Volume (1 week) | 136.85k |
Average Volume (1 Month) | 52.47k |
52 Week Change | -88.89% |
52 Week High | 5.32 |
52 Week Low | 0.22 |
Spread (Intraday) | 0.02 (4.58%) |
Company Name | Acticor Biotech |
Address |
wojo building 82 avenue du maine paris, paris 75014 |
Website | https://www.acticor-biotech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions